Click on image to view larger version.

Figure 5 Odds ratios for the primary end point (composite of cardiac end points), major cause-specific outcomes, and total mortality during the first three months of the VALUE trial after patients had been randomized to either valsartan or amlodipine monotherapy. Change in blood pressure (BP) at three months refers to the lower mean blood pressures in patients randomized to amlodipine. Data are expressed as the odds ratios ± 95% confidence intervals (CI). Figure is adapted from data extracted from Julius et al. (9).